Braveheart Bio, Inc. (BRVE) has 9 open-market insider trades by 9 insiders since 2026. Over the last six months insiders net bought $159.0M. The most active filer is Forbion Growth Opportunities Fund III Cooperatief U.A., 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Forbion Growth Opportunities Fund III Cooperatief U.A. | 10% Owner | — | 1 | $64.8M | 2026-08-07 |
| Erez Chimovits | Dir10% Owner | — | 1 | $34.9M | 2026-08-07 |
| Orbimed Advisors LLC | Dir10% Owner | — | 1 | $34.9M | 2026-08-07 |
| AH Bio Fund IV, L.P. | 10% Owner | — | 1 | $19.8M | 2026-08-07 |
| Travis Murdoch | CEOPres | — | 1 | $1.5M | 2026-08-07 |
| Christopher Viehbacher | Dir | — | 1 | $1.5M | 2026-08-07 |
| David Charles Lubner | Dir | — | 1 | $1000K | 2026-08-07 |
| James Paul Rickey | CFO | — | 1 | $500K | 2026-08-07 |
| Michele A. Anderson | — | — | 1 | $20K | 2026-08-07 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Orbimed Advisors LLC | Director & 10% Owner | Buy | $34.9M | 2026-08-07 |
| James Paul Rickey | CFO | Buy | $500K | 2026-08-07 |
| David Charles Lubner | Director | Buy | $1000K | 2026-08-07 |
| Christopher Viehbacher | Director | Buy | $1.5M | 2026-08-07 |
| AH Bio Fund IV, L.P. | 10% Owner | Buy | $19.8M | 2026-08-07 |
| Forbion Growth Opportunities Fund III Cooperatief U.A. | 10% Owner | Buy | $64.8M |
Companies that share insiders with BRVE, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2026-08-07 |
| Michele A. Anderson | — | Buy | $20K | 2026-08-07 |